Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Trump Plans To Start Notifying Countries Of US Tariffs Up To 70% Trump Plans To Start Notifying Countries Of US Tariffs Up To 70% Saudi Aramco Considers Power Assets Sale To Raise Billions Saudi Aramco Considers Power Assets Sale To Raise Billions US Stock Futures Drop On Latest Trump Tariff Salvo US Stock Futures Drop On Latest Trump Tariff Salvo US Lifts Chip Design Software Curbs On China In Trade Deal US Lifts Chip Design Software Curbs On China In Trade Deal Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment